1. Home
  2. FSTR vs HUMA Comparison

FSTR vs HUMA Comparison

Compare FSTR & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo L.B. Foster Company

FSTR

L.B. Foster Company

HOLD

Current Price

$27.37

Market Cap

299.5M

Sector

Industrials

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.16

Market Cap

229.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSTR
HUMA
Founded
1902
2004
Country
United States
United States
Employees
N/A
220
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
299.5M
229.7M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
FSTR
HUMA
Price
$27.37
$1.16
Analyst Decision
Hold
Strong Buy
Analyst Count
1
8
Target Price
$32.00
$10.00
AVG Volume (30 Days)
16.4K
4.0M
Earning Date
06-03-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
$540,009,000.00
N/A
Revenue This Year
$5.44
N/A
Revenue Next Year
$3.05
$731.05
P/E Ratio
$40.09
N/A
Revenue Growth
1.74
N/A
52 Week Low
$17.16
$0.88
52 Week High
$32.63
$3.35

Technical Indicators

Market Signals
Indicator
FSTR
HUMA
Relative Strength Index (RSI) 32.18 52.64
Support Level $25.62 $1.09
Resistance Level $28.19 $1.26
Average True Range (ATR) 1.40 0.09
MACD -0.51 0.00
Stochastic Oscillator 4.69 44.44

Price Performance

Historical Comparison
FSTR
HUMA

About FSTR L.B. Foster Company

L.B. Foster Co is a U.S-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: